Amikacin in pharma franchise in Thane

Amikacin PCD pharma franchise in Thiruvananthapuram

Amikacin in top pharma company in Assam

Amikacin In pcd pharma supplier in Dhanbad

Amikacin in phama franchise company in India
Amikacin in phama distributor in Mumbai

Home/Products /amikacin-500mg-injection

Mikatyle 500 Injection

Composition : Amikacin (500mg)

Dosage Form : Injection

Packaging Type : Vial

Packaging : 2ml

Price : ₹109/-

Mikatyle 500 Injection contains Amikacin (500mg), a potent aminoglycoside antibiotic widely used for the treatment of severe bacterial infections. It is particularly effective against gram-negative bacteria and certain gram-positive organisms. Amikacin inhibits bacterial protein synthesis, halting the growth and spread of pathogens.

This injection is primarily indicated for managing life-threatening infections such as sepsis, respiratory tract infections, complicated urinary tract infections, intra-abdominal infections, and infections of the skin, soft tissues, and bones. Its high potency and broad-spectrum activity make it a preferred choice for combating multidrug-resistant bacterial infections.

Administered via intramuscular (IM) or intravenous (IV) routes, Mikaxyle 500 Injection ensures rapid absorption and targeted action, especially in critical hospital settings. It is frequently used in cases where first-line antibiotics fail or resistance is observed.

Read More

About the Product

Mikatyle 500 Injection contains Amikacin (500mg), a potent aminoglycoside antibiotic widely used for the treatment of severe bacterial infections. It is particularly effective against gram-negative bacteria and certain gram-positive organisms. Amikacin inhibits bacterial protein synthesis, halting the growth and spread of pathogens.

This injection is primarily indicated for managing life-threatening infections such as sepsis, respiratory tract infections, complicated urinary tract infections, intra-abdominal infections, and infections of the skin, soft tissues, and bones. Its high potency and broad-spectrum activity make it a preferred choice for combating multidrug-resistant bacterial infections.

Administered via intramuscular (IM) or intravenous (IV) routes, Mikaxyle 500 Injection ensures rapid absorption and targeted action, especially in critical hospital settings. It is frequently used in cases where first-line antibiotics fail or resistance is observed.

Common side effects include: Nausea or vomiting Injection site pain or irritation Dizziness or headache Hearing impairment (ototoxicity) Kidney dysfunction (nephrotoxicity) Rare side effects may include allergic reactions, such as skin rashes, swelling, or difficulty breathing. Consult a healthcare provider for immediate assistance if severe reactions occur.

Treats severe bacterial infections of the respiratory tract, urinary tract, skin, soft tissues, bones, and bloodstream. Effective against hospital-acquired infections caused by resistant bacteria.

Use under strict medical supervision only. Regular monitoring of renal function, hearing, and drug levels in the blood is essential during prolonged treatment. Not recommended during pregnancy or breastfeeding unless deemed necessary by a healthcare professional. Ensure proper dilution before intravenous administration to prevent adverse effects.

Store at a temperature below 25°C in a dry and cool environment. Protect from direct sunlight and moisture. Do not freeze. Discard any unused solution after opening.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation